Since the initial discovery of MYCN, many prognostic biomarkers have been proposed for NB, with the most intensive studies including histopathologic classification, tumor staging, MYCN amplification, tumor cell DNA index (ploidy), and segmental chromosomal aberrations (37–39). Here, MYCN is linked to neuroblastoma.